种系TSH受体激活突变相关甲亢的基因型-表型相关性:一项系统综述。

IF 2.4 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Chethan Yamichannaiah, Saba Samad Memon, Vijaya Sarathi, Anurag Ranjan Lila, Swati Ramteke Jadhav, Puja Thadani, Samiksha Chandrashekhar Hegishte, Rohit Barnabas, Manjiri Karlekar, Aditya Phadte, Anima Sharma, Tushar Bandgar
{"title":"种系TSH受体激活突变相关甲亢的基因型-表型相关性:一项系统综述。","authors":"Chethan Yamichannaiah,&nbsp;Saba Samad Memon,&nbsp;Vijaya Sarathi,&nbsp;Anurag Ranjan Lila,&nbsp;Swati Ramteke Jadhav,&nbsp;Puja Thadani,&nbsp;Samiksha Chandrashekhar Hegishte,&nbsp;Rohit Barnabas,&nbsp;Manjiri Karlekar,&nbsp;Aditya Phadte,&nbsp;Anima Sharma,&nbsp;Tushar Bandgar","doi":"10.1111/cen.15288","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>Germline TSHR activating mutation-associated hyperthyroidism (GTAMH) manifests as sporadic or familial forms. Studies have shown poor correlation between receptor activity and clinical manifestations, highlighting a knowledge gap in understanding genotype–phenotype relationships.</p>\n </section>\n \n <section>\n \n <h3> Design</h3>\n \n <p>A classification based on age of symptom onset: infantile (<i>n</i> = 36), childhood (<i>n</i> = 33) and adulthood (&gt; 18 years, <i>n</i> = 13) was attempted by performing a systematic review of literature of GTAMH (<i>n</i> = 82 probands, including a 25-year-old woman with TSHR p.Ile640Val variant and subclinical hyperthyroidism managed at our centre). Patients were analysed for various parameters such as demographic, clinical, biochemical and genotype–phenotype correlation.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Eighty-two probands harbouring 47 different TSHR variants are reported. Probands with infantile-onset were less often familial (19.4%, <i>p</i> = 0.00) than childhood (93.9%) and adult-onset (84.6%) cases. Median serum free-T3 and T4 were highest in infantile (3.1 and 3.4 XULN) followed by childhood (1.6 and 1.9 X-ULN) and adult-onset (1.2 and 0.8 X-ULN) cases. All infant/childhood onset probands had overt hyperthyroidism, whereas 1/3 of adult-onset cases were subclinical. Most (15/18) recurrent variants were exclusive to infantile, childhood or adult-onset disease groups, except for p.Ser505Asn, p.Asp619Gly and p.Asn670Ser. Including data for probands and genetically affected family members, there was a moderate correlation for the age at diagnosis (infancy, childhood or adulthood), among family members (<i>r</i> = 0.40, <i>p</i> = 0.00), and members of multiple families harbouring the same TSHR variants (<i>r</i> = 0.46, <i>p</i> = 0.00).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>A phenotypic classification of GTAMH into infantile-onset severe hyperthyroxinemia (mostly due to de novo variants), childhood-onset overt hyperthyroidism or adulthood-onset overt/subclinical hyperthyroidism correlates with the genotype of TSHR variants, may guide patient management.</p>\n </section>\n </div>","PeriodicalId":10346,"journal":{"name":"Clinical Endocrinology","volume":"103 2","pages":"119-128"},"PeriodicalIF":2.4000,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cen.15288","citationCount":"0","resultStr":"{\"title\":\"Genotype–Phenotype Correlation in Germline TSH Receptor Activating Mutation Associated Hyperthyroidism: A Systematic Review\",\"authors\":\"Chethan Yamichannaiah,&nbsp;Saba Samad Memon,&nbsp;Vijaya Sarathi,&nbsp;Anurag Ranjan Lila,&nbsp;Swati Ramteke Jadhav,&nbsp;Puja Thadani,&nbsp;Samiksha Chandrashekhar Hegishte,&nbsp;Rohit Barnabas,&nbsp;Manjiri Karlekar,&nbsp;Aditya Phadte,&nbsp;Anima Sharma,&nbsp;Tushar Bandgar\",\"doi\":\"10.1111/cen.15288\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Objective</h3>\\n \\n <p>Germline TSHR activating mutation-associated hyperthyroidism (GTAMH) manifests as sporadic or familial forms. Studies have shown poor correlation between receptor activity and clinical manifestations, highlighting a knowledge gap in understanding genotype–phenotype relationships.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Design</h3>\\n \\n <p>A classification based on age of symptom onset: infantile (<i>n</i> = 36), childhood (<i>n</i> = 33) and adulthood (&gt; 18 years, <i>n</i> = 13) was attempted by performing a systematic review of literature of GTAMH (<i>n</i> = 82 probands, including a 25-year-old woman with TSHR p.Ile640Val variant and subclinical hyperthyroidism managed at our centre). Patients were analysed for various parameters such as demographic, clinical, biochemical and genotype–phenotype correlation.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Eighty-two probands harbouring 47 different TSHR variants are reported. Probands with infantile-onset were less often familial (19.4%, <i>p</i> = 0.00) than childhood (93.9%) and adult-onset (84.6%) cases. Median serum free-T3 and T4 were highest in infantile (3.1 and 3.4 XULN) followed by childhood (1.6 and 1.9 X-ULN) and adult-onset (1.2 and 0.8 X-ULN) cases. All infant/childhood onset probands had overt hyperthyroidism, whereas 1/3 of adult-onset cases were subclinical. Most (15/18) recurrent variants were exclusive to infantile, childhood or adult-onset disease groups, except for p.Ser505Asn, p.Asp619Gly and p.Asn670Ser. Including data for probands and genetically affected family members, there was a moderate correlation for the age at diagnosis (infancy, childhood or adulthood), among family members (<i>r</i> = 0.40, <i>p</i> = 0.00), and members of multiple families harbouring the same TSHR variants (<i>r</i> = 0.46, <i>p</i> = 0.00).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>A phenotypic classification of GTAMH into infantile-onset severe hyperthyroxinemia (mostly due to de novo variants), childhood-onset overt hyperthyroidism or adulthood-onset overt/subclinical hyperthyroidism correlates with the genotype of TSHR variants, may guide patient management.</p>\\n </section>\\n </div>\",\"PeriodicalId\":10346,\"journal\":{\"name\":\"Clinical Endocrinology\",\"volume\":\"103 2\",\"pages\":\"119-128\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-06-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cen.15288\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Endocrinology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/cen.15288\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cen.15288","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

目的:种系TSHR激活突变相关性甲状腺功能亢进症(GTAMH)表现为散发或家族形式。研究表明,受体活性与临床表现之间的相关性较差,突出了对基因型-表型关系的认识差距。设计:根据症状发病年龄进行分类:婴儿(n = 36)、儿童(n = 33)和成年(n = 18岁,n = 13),通过对GTAMH文献(n = 82先证,包括一名25岁的TSHR p.i ile640val变异和亚临床甲状腺功能亢进在我们中心治疗)进行系统回顾。分析患者的各种参数,如人口学、临床、生化和基因型-表型相关性。结果:共报道了82个先证者,其中包含47个不同的TSHR变异。婴儿起病的先发基因的家族性发生率(19.4%,p = 0.00)低于儿童起病(93.9%)和成人起病(84.6%)。血清游离t3和T4中位数最高的是婴儿(3.1和3.4 X-ULN),其次是儿童(1.6和1.9 X-ULN)和成人(1.2和0.8 X-ULN)。所有婴儿/儿童发病先证者均有明显的甲亢,而1/3的成人发病病例为亚临床。除p.Ser505Asn、p.s er619gly和p.s ern670ser外,大多数(15/18)复发变异只发生在婴儿、儿童或成人发病组。包括先证和受遗传影响的家庭成员的数据,诊断年龄(婴儿期、儿童期或成年期)、家庭成员(r = 0.40, p = 0.00)和多个拥有相同TSHR变异的家庭成员(r = 0.46, p = 0.00)之间存在中度相关性。结论:GTAMH的表型分类与TSHR变异的基因型相关,分为婴儿期发病的严重甲亢(主要由新生变异引起)、儿童期发病的显性甲亢或成年期发病的显性/亚临床甲亢,可能指导患者的治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Genotype–Phenotype Correlation in Germline TSH Receptor Activating Mutation Associated Hyperthyroidism: A Systematic Review

Genotype–Phenotype Correlation in Germline TSH Receptor Activating Mutation Associated Hyperthyroidism: A Systematic Review

Objective

Germline TSHR activating mutation-associated hyperthyroidism (GTAMH) manifests as sporadic or familial forms. Studies have shown poor correlation between receptor activity and clinical manifestations, highlighting a knowledge gap in understanding genotype–phenotype relationships.

Design

A classification based on age of symptom onset: infantile (n = 36), childhood (n = 33) and adulthood (> 18 years, n = 13) was attempted by performing a systematic review of literature of GTAMH (n = 82 probands, including a 25-year-old woman with TSHR p.Ile640Val variant and subclinical hyperthyroidism managed at our centre). Patients were analysed for various parameters such as demographic, clinical, biochemical and genotype–phenotype correlation.

Results

Eighty-two probands harbouring 47 different TSHR variants are reported. Probands with infantile-onset were less often familial (19.4%, p = 0.00) than childhood (93.9%) and adult-onset (84.6%) cases. Median serum free-T3 and T4 were highest in infantile (3.1 and 3.4 XULN) followed by childhood (1.6 and 1.9 X-ULN) and adult-onset (1.2 and 0.8 X-ULN) cases. All infant/childhood onset probands had overt hyperthyroidism, whereas 1/3 of adult-onset cases were subclinical. Most (15/18) recurrent variants were exclusive to infantile, childhood or adult-onset disease groups, except for p.Ser505Asn, p.Asp619Gly and p.Asn670Ser. Including data for probands and genetically affected family members, there was a moderate correlation for the age at diagnosis (infancy, childhood or adulthood), among family members (r = 0.40, p = 0.00), and members of multiple families harbouring the same TSHR variants (r = 0.46, p = 0.00).

Conclusion

A phenotypic classification of GTAMH into infantile-onset severe hyperthyroxinemia (mostly due to de novo variants), childhood-onset overt hyperthyroidism or adulthood-onset overt/subclinical hyperthyroidism correlates with the genotype of TSHR variants, may guide patient management.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical Endocrinology
Clinical Endocrinology 医学-内分泌学与代谢
CiteScore
6.40
自引率
3.10%
发文量
192
审稿时长
1 months
期刊介绍: Clinical Endocrinology publishes papers and reviews which focus on the clinical aspects of endocrinology, including the clinical application of molecular endocrinology. It does not publish papers relating directly to diabetes care and clinical management. It features reviews, original papers, commentaries, correspondence and Clinical Questions. Clinical Endocrinology is essential reading not only for those engaged in endocrinological research but also for those involved primarily in clinical practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信